High-dose intravenous vitamin C attenuates hyperinflammation in severe coronavirus disease 2019

OBJECTIVE: High-dose intravenous vitamin C (HIVC) is a major concern when treating patients with coronavirus disease 2019 (COVID-19). The aim of this study was to assess the clinical efficacy of HIVC on hyperinflammation in patients with severe COVID-19. METHODS: This retrospective cohort study incl...

Descripción completa

Detalles Bibliográficos
Autores principales: Xia, Guozhi, Fan, Di, He, Yanru, Zhu, Yaohu, Zheng, Qiangsun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2021
Materias:
Applied Nutritional Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8234258/
https://www.ncbi.nlm.nih.gov/pubmed/34388587
http://dx.doi.org/10.1016/j.nut.2021.111405

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8234258/
https://www.ncbi.nlm.nih.gov/pubmed/34388587
http://dx.doi.org/10.1016/j.nut.2021.111405

Ejemplares similares